ABEONA THERAPEUTICS INC. Earnings Per Share Diluted

• ABEONA THERAPEUTICS INC. showed an increase of +165.2% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from ABEONA THERAPEUTICS INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
• XBRL data for this metric is available from 2012 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $0.07 per share | Q1 2011: $0.12 (loss) per share | Q2 2011: $0.09 (loss) per share | Q1 2012: $0.22 (loss) per share | Q2 2012: $0.46 (loss) per share | Q3 2012: $0.63 (loss) per share | Q1 2013: $0.13 per share | Q2 2013: $0.03 per share | Q3 2013: $1.77 (loss) per share | Q1 2014: $0.03 (loss) per share | Q2 2014: $0.51 (loss) per share | Q3 2014: $4.15 (loss) per share | Q2 2022: $1.36 per share | Q3 2022: $1.00 (loss) per share | Q1 2023: $0.54 (loss) per share | Q2 2023: $0.92 (loss) per share | Q3 2023: $0.48 (loss) per share | Q1 2024: $1.16 (loss) per share | Q2 2024: $0.26 (loss) per share | Q3 2024: $0.63 (loss) per share | Q1 2025: $0.24 (loss) per share | Q2 2025: $1.71 per share | Q3 2025: $0.10 (loss) per share.
• Over the full 7 years of available data (2012 to 2025), ABEONA THERAPEUTICS INC.'s Earnings Per Share Diluted has grown by 294.2%.
• Historical annual values: Fiscal year 2025: $1.01 per share | Fiscal year 2024: $1.55 (loss) per share | Fiscal year 2023: $2.53 (loss) per share | Fiscal year 2022: $5.53 (loss) per share | Fiscal year 2014: $15.26 (loss) per share | Fiscal year 2013: $3.04 per share | Fiscal year 2012: $0.52 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026